1. Home
  2. WLKP vs CADL Comparison

WLKP vs CADL Comparison

Compare WLKP & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westlake Chemical Partners LP

WLKP

Westlake Chemical Partners LP

HOLD

Current Price

$22.29

Market Cap

798.3M

Sector

Industrials

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$9.85

Market Cap

754.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLKP
CADL
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
798.3M
754.7M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
WLKP
CADL
Price
$22.29
$9.85
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.00
AVG Volume (30 Days)
20.3K
2.0M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
8.25%
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
$1,166,695,000.00
$125,000.00
Revenue This Year
$19.48
N/A
Revenue Next Year
$5.24
N/A
P/E Ratio
$15.30
N/A
Revenue Growth
2.71
N/A
52 Week Low
$17.75
$4.35
52 Week High
$23.88
$11.36

Technical Indicators

Market Signals
Indicator
WLKP
CADL
Relative Strength Index (RSI) 39.02 60.25
Support Level $22.14 $4.89
Resistance Level $22.30 N/A
Average True Range (ATR) 0.41 0.64
MACD -0.07 0.05
Stochastic Oscillator 17.73 54.81

Price Performance

Historical Comparison
WLKP
CADL

About WLKP Westlake Chemical Partners LP

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: